However, molecular effects through the associated competitive endogenous (ceRNA) of miR-140-3p-GPRIN1 axis of LINC02298 [50], or through cytochrome c oxidase subunit 6C (COX6C) function, as found in other neurological diseases [51], may still be possible. This evidence concerns the gene GPRIN1 and nervous system disorder.